Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
189
-
Total 13F shares, excl. options
-
18,056,758
-
Shares change
-
+242,322
-
Total reported value, excl. options
-
$4,359,366,474
-
Value change
-
+$41,949,643
-
Put/Call ratio
-
118%
-
Number of buys
-
115
-
Number of sells
-
-81
-
Price
-
$241.38
Significant Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q2 2015
248 filings reported holding ICPT - INTERCEPT PHARMACEUTICALS IN - COM as of Q2 2015.
INTERCEPT PHARMACEUTICALS IN - COM (ICPT) has 189 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,056,758 shares
.
Largest 10 shareholders include FMR LLC (3,610,846 shares), Ameriprise Financial Inc (1,496,079 shares), Carmignac Gestion (1,324,607 shares), ORBIMED ADVISORS LLC (1,120,000 shares), VANGUARD GROUP INC (1,001,214 shares), Capital World Investors (780,000 shares), FRED ALGER MANAGEMENT INC (513,069 shares), FIRST TRUST ADVISORS LP (487,459 shares), BlackRock Fund Advisors (450,015 shares), and BlackRock Institutional Trust Company, N.A. (346,048 shares).
This table shows the top 189 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.